Land: Írland
Tungumál: enska
Heimild: HPRA (Health Products Regulatory Authority)
Acetylsalicylic acid
Reckitt Benckiser Ireland Ltd
N02BA; N02BA01
Acetylsalicylic acid
300 milligram(s)
Dispersible tablet
Product not subject to medical prescription
Salicylic acid and derivatives; acetylsalicylic acid
Marketed
1978-04-01
PACKAGE LEAFLET: INFORMATION FOR THE USER Disprin Original 300mg Dispersible Tablets ASPIRIN (acetylsalicylic acid) Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. • Keep this leaflet. You may need to read it again. • Ask your pharmacist if you need more information or advice. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. • You must talk to a doctor if you do not feel better or if you feel worse after 24 hours. WHAT IS IN THIS LEAFLET 1. What Disprin Original is and what is it used for 2. What you need to know before you take Disprin Original 3. How to take Disprin Original 4. Possible side-effects 5. How to store Disprin Original 6. Contents of the pack and other information. 1. WHAT DISPRIN ORIGINAL IS AND WHAT IT IS USED FOR The ingredients that makes Disprin Original work (the active ingredient) is Aspirin. Aspirin belongs to a group of medicines know as non-steroidal anti-inflammatory drugs (NSAIDs). It works to relieve pain and inflammation. Disprin Original can be used to • relieve mild to moderate pain (such as headache, toothache and nerve pain) • reduce temperature and inflammation, such as lower back pain. • relief in upper respiratory tract infections 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DISPRIN ORIGINAL DO NOT TAKE DISPRIN ORIGINAL IF YOU • are ALLERGIC to or have ever had an allergic reaction to aspirin or to other non-steroidal anti- inflammatory drugs or to any of the other ingredients (see section 6). Allergic reactions may include wheeziness, runny nose, itchy skin rash • have or have ever had a STOMACH ULCER, PERFORATION OR BLEEDING • have or have ever had a BLEEDING DISORDER • have severe LIVER OR KIDNEY PROBLEMS • are in the last 3 MONTHS OF PREGNANCY or are BREAST-FEEDING • are under Lestu allt skjalið
Health Products Regulatory Authority 28 September 2022 CRN00CT1Q Page 1 of 8 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Disprin Original 300 mg Dispersible Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 300 mg of acetylsalicylic acid. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Dispersible tablet. White, flat, circular, bevel-edged dispersible tablets with the ‘Sword’ motif and the word ‘Disprin’ engraved on one face, plain on reverse. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the relief of mild to moderate pain, such as is associated with headache, toothache, neuralgia and period pains. Symptomatic relief in upper respiratory tract infections (such as feverishness, cold and flu, sore throat). Reduction of inflammation, such as in lumbago. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION The lowest effective dose should be used for the shortest duration necessary to relieve symptoms. POSOLOGY Adults and children aged 16 and over: One to two tablets every 4-6 hours to a maximum of 12 tablets in 24 hours. Do not give to children and adolescents aged under 16 years, except on medical advice, where the benefit outweighs the risk. HEPATIC IMPAIRMENT: Patients with hepatic impairment should seek the advice of a doctor before taking this product (see sections 4.3 and 4.4). RENAL IMPAIRMENT: Patients with renal impairment should seek the advice of a doctor before taking this product (see sections 4.3 and 4.4). ELDERLY: Non-steroidal anti-inflammatory drugs should be used with particular caution in elderly patients who are more prone to adverse events. The lowest dose compatible with adequate safe clinical control should be employed. (See also Section 4.4). METHOD OF ADMINISTRATION Oral administration after dissolution in water. 4.3 CONTRAINDICATIONS Hypersensitivity to acetylsalicylic acid or to any of the excipients listed in section 6.1. Hypersensitivity to other non-steroidal anti-inflammatory drugs. Health Products Regulatory A Lestu allt skjalið